Panagora Asset Management’s Dare Bioscience DARE Stock Holding History

Panagora Asset Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,626	Closed	-$14K	–	2520
2018 Q4	$14K	Sell	1,626 -5,107	-76%	-$53.8K	﹤0.01%	2281
2018 Q3	$79K	Sell	6,733 -1,121	-14%	-$15.1K	﹤0.01%	1920
2018 Q2	$110K	Buy	7,854 +4,588	+140%	+$61.3K	﹤0.01%	1816
2018 Q1	$33K	Buy	3,266 +2,779	+571%	+$56.2K	﹤0.01%	2134
2017 Q4	$13K	Buy	+487	New	+$15.6K	﹤0.01%	2207

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Panagora Asset Management's DARE Position: Q1 2019 in Review

Panagora Asset Management sold out of Dare Bioscience (DARE) in Q1 2019, closing a stake of 1,626 shares — an estimated $14K sold.

Panagora Asset Management first reported a position in DARE in Q4 2017 and held it in 5 quarters. The position peaked at $110K in Q2 2018. 14 funds tracked by Wall St. Rank hold DARE as of Q1 2019.

Panagora Asset Management reported no remaining Dare Bioscience position as of Q1 2019 after selling out during the quarter.
Panagora Asset Management sold 1,626 Dare Bioscience shares in Q1 2019, an estimated $14K.
Panagora Asset Management first reported a position in Dare Bioscience in Q4 2017 and held it in 5 quarters.
Panagora Asset Management's Dare Bioscience position peaked at $110K in Q2 2018.
14 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2019.

Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.